Translate
Citius Oncology, Inc.
About
Citius Oncology, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization
Apr 29 2026
Citius Oncology Ships First International Order of LYMPHIR™ to Europe
Apr 24 2026
Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules
Mar 31 2026
Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development
Mar 24 2026
Citius Oncology to Participate in USCLC Annual Workshop 2026, Highlighting LYMPHIR™ in Discussions with Leading Cutaneous Lymphoma Experts
Recent Videos
Cómo invertir en Citius Oncology Inc (CTOR) paso a paso
Apr 09, 2026
Citius Pharma's 8-K: My Focus on LYMPHIR Launch Success
Apr 02, 2026
DBC Webinar - Citius Pharmaceuticals: From Development Stage to Commercial Oncology
Mar 12, 2026
My Take on Citius Oncology's "Going Concern" Red Flag
Feb 24, 2026